Table 1 Clinical data of the patients with RESLES
From: Reversible splenial lesion syndrome with mental disorders as only manifestation
Patient ID | Age/ gender | Clinical symptoms | Clinical diagnosis | Treatment | Outcome (hospital stays, days) | |
|---|---|---|---|---|---|---|
1 | 34/M | alcohol dependence/refusal of food intake/depressive | Alcohol dependence with withdrawal | Diazepam/ Oxazepam/ Mirtazapine/ Vitamin B complex | CR (13) | |
2 | 26/M | alcohol dependence/depressive/auditory hallucination/delusion | Alcohol dependence with alcohol-induced psychotic disorder | Diazepam/ Paliperidone/ Valproate/ Vitamin B complex | CR (9) | |
3 | 28/M | sensitive/suspicious/loneliness/impaired personal hygiene/irregular intake | Asperger’s syndrome | Aripiprazole/ Mirtazapine/ Vitamin B complex | PR (27d) | |
4 | 14/M | behavioral abnormalities/irrelevant talking/auditory hallucination | Other specified mental disorders due to known physiological condition | Olanzapine/ Clonazepam | T/CR (5d) | |
5 | 51/F | delusion/ auditory hallucination/ depressive | Other specified mental disorders due to known physiological condition | Quetiapine/ Lorazepam | T/PR (2d) | |
6 | 20/F | stupor/depressive | Major depressive disorder, single episode, severe with psychotic features | Quetiapine/ Escitalopram | T/PR (2d) | |
7 | 28/F | depressive/behavioral abnormalities/ irrelevant talking/disturbed sleep | Dissociative and conversion disorders | Olanzapine | PR (26d) | |
8 | 27/M | persistent headache/ | undifferentiated somatoform disorder | Duloxetine / Valproate / Olanzapine | PR (43d) | |
9 | 28/M | delusion/behavioral abnormalities/disturbed sleep | Unspecified psychosis not due to a substance or known physiological condition | Ziprasidone / Quetiapine | PR (26) | |
10 | 31/F | elevated mood/decreased need for sleep/greater talkativeness | Bipolar disorder, current episode manic severe with psychotic features | Quetiapine/ Lithium carbonate | PR (14d) | |